GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (OTCPK:ATHJF) » Definitions » Price-to-Tangible-Book
中文

Percheron Therapeutics (Percheron Therapeutics) Price-to-Tangible-Book : 0.83 (As of Apr. 25, 2024)


View and export this data going back to . Start your Free Trial

What is Percheron Therapeutics Price-to-Tangible-Book?

As of today (2024-04-25), Percheron Therapeutics's share price is $0.01. Percheron Therapeutics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.01. Hence, Percheron Therapeutics's Price to Tangible Book Ratio of today is 0.83.

The historical rank and industry rank for Percheron Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Percheron Therapeutics's highest Price to Tangible Book Ratio was 19.50. The lowest was 1.09. And the median was 3.93.

ATHJF's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.32
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Percheron Therapeutics's share price is $0.01. Percheron Therapeutics's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.01. Hence, Percheron Therapeutics's P/B Ratio of today is 0.83.


Percheron Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Percheron Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Percheron Therapeutics Price-to-Tangible-Book Chart

Percheron Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.70 8.33 17.54 3.18 5.00

Percheron Therapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.77 3.18 4.06 5.00 0.83

Competitive Comparison of Percheron Therapeutics's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Percheron Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Percheron Therapeutics's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Percheron Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Percheron Therapeutics's Price-to-Tangible-Book falls into.



Percheron Therapeutics Price-to-Tangible-Book Calculation

Percheron Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=0.01/0.012
=0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Percheron Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Percheron Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Percheron Therapeutics (Percheron Therapeutics) Business Description

Traded in Other Exchanges
Address
14 Wallace Avenue, Toorak, VIC, AUS, 3142
Antisense Therapeutics Ltd is a drug manufacturer. The company is engaged in research and development of novel antisense pharmaceuticals. The company operates in two segments that have been identified based on its antisense oligonucleotide products as ATL1102 and ATL1103.